HomeNSRX • NYSEAMERICAN
add
Nasus Pharma Ltd
Previous close
$6.52
Day range
$6.50 - $6.53
Year range
$5.90 - $9.99
Market cap
58.58M USD
Avg Volume
6.81K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 408.50K | 69.15% |
Net income | -626.00K | -43.74% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 203.00K | -77.44% |
Total assets | 639.00K | -37.35% |
Total liabilities | 4.95M | -12.85% |
Total equity | -4.31M | — |
Shares outstanding | 7.36M | — |
Price to book | -11.05 | — |
Return on assets | -159.82% | — |
Return on capital | 58.32% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -626.00K | -43.74% |
Cash from operations | -216.50K | -140.56% |
Cash from investing | — | — |
Cash from financing | 180.00K | -59.14% |
Net change in cash | -39.50K | -111.19% |
Free cash flow | -180.31K | -17.04% |
About
Founded
2019
Website
Employees
2
